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The furocoumarin group of compounds include
psoralen, 8-methoxypsoralen (Methoxsalen or
xanthotoxin) and other related compounds. The
leaves and fmits of plants containing naturally
occurring furocoumarins have been used for
centuries in Egypt (1, 2, 3, 4), India (5, 6, 7) and
other oriental countries in the treatment of skin
depigmentation. 8-methoxypsoralen (8-MOP)
has been used more recently in the treatment of
vitiligo (Sekla 8, Sidi and associate 0, Lerner et
at. 10). In addition, Musajo (11), Fitzpatrick, et
at. (12) have reported increased pigmentation
of skin in individuals exposed to sunlight in
presence of this compound. Musajo et at. (13)
have also investigated the relative activity of
these compounds when applied topically to
human skin. Fowlks, et al. (14) from this labora-
tory have recently reported the photosensitiza-
tion effect of furocoumarin, coumarin and several
other substances on bacteria in presence of long
wave ultraviolet light (> 3200A).
The purpose of this investigation was (a) to
set up a bioassay method using mammalian
albino guinea pig skin to study the relative activ-
ity of these compounds, (b) to correlate the
erythema inducing property of various com-
pounds in terms of molecular configuration, (c)
to determine the minimum effective concentra-
tion of different compounds on guinea pig skin
and correlate this data with the results obtained
with human skin.
It appears that albino guinea pig skin can be
conveniently used for assaying the photodynamic
activity of these compounds. Using long wave
ultraviolet light of 3200 A and above wave length,
erythema and pigment inducing compounds can
be given orally or applied topically and tested for
their relative activity.
MATERIALS AND METUOPS
Photodynamic chemicals are known to induce
erythema and residual pigmentation of skin fol-
Presented at the Nineteenth Annual Meeting of
The Society for Investigative Dermatology, Inc.,
San Francisco, California, June 22, 1958. Thispresentation is an extension of the preliminary
observations (Relationship of Molecular Config-
uration to the Activity of Furocoumarins, J. I. D.
32, p. 255, Feb. 1959 (Part II)).
* From the Division of Dermatology, University
of Oregon Medical School, Portland, Oregon.
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lowing solar radiation. Human skin, though ideal
for evaluating this photodynamic response, is
not easily available for large scale screening. In
order to determine the relative activity of various
compounds and study the relationship of mo-
lecular configuration to the activity of furocou-
marins, coumarins and other related compounds,
a bioassay method using albino guinea pigs has
been developed. By this method, the minimum
effective oral or topical concentration for induc-
ing erythema can be determined. Also the relative
photodynamic activity of various compounds in
terms of biological response can be evaluated.
Albino guinea pigs weighing 400 to 600 grams
were used. Initially the hair was clipped and a
mild depilatory applied to make the skin smooth
and completely free from projecting hair. Under
warm tap water the animal was thoroughly cleaned
and subsequently rested for an hour or so. An
adhesive tape 7.5 cm. wide and 15 cm. long, hay-
jag eight 2.5 cm. square windows was prepared
each time and fixed on the back of guinea pig. The
animal was kept supine on a wooden board facing
the ultraviolet light source. The guinea pig was
immobilized by securing the legs. Varying con-
centrations of different compounds ranging from
2.5 g to 2000 ig dissolved in 95% ethanol were
applied topically in each 2.5 cm. square window
area. In each area, 0.1 to 0.2 ml. of the solution
was applied gradually and uniformly with the aid
of small graduated micropipette. In blank area
0.2 ml. of 95% ethanol was applied. Initially, at
least three different concentrations (100 ug to
500 g) of each compound were applied to evaluate
the range of effective concentration and finally
when the compound was known to be photo-
dynamically active, a series of solutions containing
2.5, 5, 10, 15, 25, 50, 100, 150, 200 zg of the com-
pound were applied in separate 2.5 cm. square
windows to determine the minimum effective con-
centration of the compound which was essential
to produce clearly perceptible erythema.
In the oral studies, the compound was weighed
in small capsules and administered quantitatively
on a weight basis. To facilitate complete intake of
the substance, a small amount of water was also
given by means of a dropper. The minimum effec-
tive concentration of the compound required to
produce clearly visible erythema orally was deter-
mined by gradually feeding increasing doses of the
compound until a definite erythema response was
observed. In human subjects the relative activity
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TABLE II
Relative activity of coumarin derivatives
6 j I
Coumarin
1. Coumarin
2. 7-Hydroxycoumarin (umbelliferone)
3. 4-Hydroxycoumarin
4. 7-Hydroxy-4-methylcoumarin (4-methylumbellife-
rone)
5. 3-Methylcoumarin
6. 4-Methylcouniarin
7. 6-Methylcoumarin
8. 7-Metliylcoumarin
9. 5, 7-Dimethylcoumarin
10. 6, 7-Dimethylcoumarin
11. 4,5, 7-Trimethylcoumarin
12. 3-Ethylcoumarin
13. 3, 4-Dihydro-5-methylcoumarin
14. 3, 4-Dihydro-6-methylcoumarin
15. 3,4-Dihydro-7-methylcoumarin
16. 3, 4-Dihydro-6, 7-dimethylcoumarin
17. 5, 7-Dihydroxy-4-methylcoumarin
18. 8-Isopropyl-5-methylcoumarin
19. 4-Methyl-7-ethoxycoumarin
20. 2-Thiocoumarin
21. 3-Chiorocoumarin
22. 4-a-Methylbenzocoumarin
23. 4-13-Methylbenzocoumarin
24. Aesculine (6, 7-dihydroxy-6-glucoside)
0
25. 7-Acetoxy-4-methylcoumarin, 7- (O—C-—-CH3)
26. 7-Allyloxycoumarin, 7-(O----C112—-CH=C112)
27. j3-Methyl a-napthylcoumarin
28. 5, 7-Dimethoxycoumarin (limetin)
inactive
inactive
inactive
active ++ 200
jzg/sq. in.
No response 30 mg/kg
No response 25 mg/kg
No response 25 mg/kg
No response 33 mg/kg
No response 26.1 mg/kg
No response 28.6 mg/kg
No response 28.6 mg/kg
No response 25.3 mg/kg
No response 25 mg/kg
No response 20 mg/kg
of these compounds was tested topically. The inner
side of forearms of 12 normal volunteers were
shaved and adhesive tapes applied similarly as
described earlier.
Lag period and total ultraviolet radiation time:
In testing the photodynamic activity of the
compounds either topically or orally, the opti-
mum lag period must be ascertained before
reproducible responses can be obtained. In the
guinea pig bioassay (topical studies), a lag
period of 30 minutes was found to be adequate
to elicit a response. In human subjects similarly,
a 30 minutes lag period after applying the com-
pound topically was found to give a response. In
oral studies with guinea pigs, a minimum of 13/
hours lag period was required before an optimum
response of orally injested compound could be
Compound
Erythemal Response (Guinea Pig Skin)
Topical effect 1000
g/2.5 cm2 Oral effect mg/kg
No response 30 mg/kg
No response 30 mg/kg
No response 30 mg/kg
inactive
inactive
inactive
inactive
inactive
inactive
inactive
inactive
inactive
inactive
inactive
inactive
inactive
inactive
inactive
inactive
inactive
inactive
inactive
+
inactive
inactive
inactive
inactive
No response 25 mg/kg
No response 20 mg/kg
TABLE 111
Relative activity of furochroniones and other compounds
Compound Structure Topical erythemalresponse (guinea pig skin)
1. Khellin 0C115
CH(O\(OL
OCH
Inactive 1000 pg/2.5 cm2
2. Chellol glucoside (2-glucosoxy methyl-
5-methoxy furochromone)
C112006111105
/O'\,/'\/O\/'
uYyI
00118
Inactive 1000 zg/2.5 cm2
3. Visnagin CH(O\\/OLu
OC11
Inactive 1000 ,g/2.5 cm2
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Other Compounds
HC(°"]C11
110L_i011
Inactive 1000 ,zg/2.5 cm21. Furan
2. Benzofuran
3. Furacin (5-nitro-2-furaldehyde amino
guanidine 1101)
4. Cinnamic acid
Inactive 1000 /Lg/2.5 cm2
NH
02N °"CH:NNHC(1101) \
NH2
Inactive 1000 g/2.5 cm2
Inactive 1000 ,zg/2.5 cm2
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shown. A lag period of 30 to 45 minutes in topical
testing and 90 to 105 minutes in oral testing was
therefore observed throughout this study. For
topical as well as oral studies with guinea pigs, a
total radiation time of 45 minutes under long
wave ultraviolet light (>3200 A) was found to
give a maximum response. A radiation time of 15
or 30 minutes was inadequate. In human sub-
jects, 15 minutes radiation time was found to be
sufficient for inducing photodynamic response.
Longer exposures resulted in harmful effects
(vesication, edema, etc.).
In all these studies the distance between lamp
and the irradiated skin was kept constant (12
cm.). Excessive heating was minimized by blow-
ing air on to the test area.
The degree of erythema present at the end of
18 and 36 hours after radiation was employed as
a measure of relative activity of the compound.
The degree of erythema was read on a Photovolt
photoelectric reflection meter Model 610 operated
on A. C. power line, (Photovolt Corporation,
New York) with a red and green tristimulus
standard filters using a calibrated enamel plaque
as a working standard. The erythema has been
expressed as per cent reflectance difference from
adjacent control skin area through the green
tristimulus filter. Visible erythema has been also
recorded in terms of a scale of — to + + + + as
described below:
— = no erythema
= just barely visible erythema equiv-
alent to 2% difference between
control area and the test area with
tristimulus green filter.
+ = clearly visible erythema of low
intensity equivalent to 4% differ-
ence.
+ + = moderate erythema (pink red)
equivalent to 6% difference.
+ + + = marked erythema (red) equivalent
to 9% difference.
+ + + + = marked erythema with vesication,
edema, etc. equivalent to any
difference in reflectance greater
than 9%.
The degree of pigmentation was evaluated after
an interval of 7 days and 15 days. The pigmenta-
tion response on human skin has been expressed
similarly on a graded scale of — to + + + +, of
increasing intensity.
In topical as well as oral studies, care has to be
taken to avoid exposure of the skin directly to
any fluorescent light or sunlight before and after
radiation.
Ultraviolet light source: All investigations re-
ported in the present studies were carried out with
long wave ultraviolet light. The principal emission
of the lamp is the 3654A band of mercury are spec-
trum. The black light unit model 70 GLO-CRAFT,
250 watt (Switzer Brothers Inc. Cleveland, Ohio)
operated on 110 volts line current has a pressed
glass ROUNDEL filter * 41 which fails to trans-
mit all the wave lengths below 3200k and above
4000A. With this filter there is 52% light trans-
mission at 3650A, 25% transmission at 3400A and
35% transmission at 3800k.
RESULTS
In table I the relative activity of eighteen
furocoumarins on albino guinea pig skin and
human skin has been summarized. The various
concentrations expressed in topical studies
(guinea pig skin and human skin) represent only
those concentrations which induce definite per-
ceptible erythema. In order to conserve space and
at the same time demonstrate the relative activity
response, results with two different concentrations
for each compound have been shown. The low
concentration data also represents the minimum
effective concentration which is required to pro-
duce a clearly perceptable erythema. The ery-
thema and the pigment response for the different
concentrations of each compound was investi-
gated at least for three times on different subjects
and finally mean response has been presented for
each concentration. To illustrate the comparative
response, different concentrations in g per 2.5
cm. square area have been expressed in terms
of millimols. The compounds labelled as inactive
did not produce any erythemal response up to
the range of 1000 to 2000 g per 2.5 cm. square
area of the skin. The intensity of erythema has
been expressed in + or — signs as stated earlier
and as reflectance difference between the adjacent
control area and the area radiated in presence of
photodynamic agent.
In oral studies (guinea pigs only) the effective
concentrations which definitely exhibited ery-
thema are shown. Concentrations below and
above this effective range were also studied, but
the results have not been included. Only the
minimum concentration which produced cry-
thema for each compound has been presented in
a manner as stated earlier.
The relative activity of coumarin derivatives
BIOASSAY OF FUROCOUMARINS (PSORALENS) 515
(topical as well as oral) is presented in table II.
Twenty-eight different coumarin derivatives
were applied on guinea pig back topically in con-
centrations ranging from 100 to 1000 jig per 2.5
cm. square area of the skin. Only the highest
concentration response has been shown. These
different coumarin derivatives represent a spec-
trum of different substituting radicals at various
carbon atoms. This was purposely investigated
to determine whether methyl, ethyl, hydroxyl,
ethoxy, acetoxy, chloro, thio, etc. substituting
groups at various carbon atoms in coumarin
molecule exhibited any photodynamic action.
In testing the photodynamie activity of these
coumarins given orally, only a selected few deriv-
atives were studied.
The relative activity of compounds possessing
the furochromone ring configuration and furan
ring configuration is shown in table III.
It can be seen (table I) that out of eighteen
furocoumarins which were tested topically, eleven
showed photodynamie action. Psoralen, 4,5' ,8-
trimethylpsoralen, 5', 8-dimethylpsoralen, 5'-
methyipsoralen, 8-methoxypsoralen, 5-methoxy-
psoralen and psoralen glucoside were active
topically as well as orally. Compounds such as
8-isoamyleneoxypsoralen, 4' ,5'-dihydropsoralen,
4, 5'-dimethylisopsoralen, and 5-methoxyiso-
psoralen were active topically at higher concen-
trations only and when given orally even in high
doses (20 to 25 mg/kg) showed no photodynamic
response. The compounds 4-methyl-4' , 5'-dihydro-
psoralen, psoralenquinone, 2-thiofurocoumarin,
5 ,8-dimethoxypsoralen (isopimpinellin), 5-nitro-
8-methoxypsoralen, 5-amino, 8-methoxypsoralen,
8-hydroxypsoralen were inactive topically as
well as orally. The order of activity of various
furocoumarins when given orally or applied
topically (taking into consideration the millimol
concentration and the response of erythema and
pigmentation) was as follows: psoralen,
4,5', 8-trimethyipsoralen, 5', 8-dimethylpsoralen,
5'-methylpsoralen, 8-methoxypsoralen, 5-meth-
oxypsoralen, psoralen glucoside. All the methyl
derivatives were almost as active as psoralen. On
guinea pig skin trimethylpsoralen showed
slightly more erythema response than psoralen
but on human skin it was less active. On human
skin not only the erythema response of these
methyl derivatives was relatively less than
psoralen but also the final pigmentation response
was less. In general, these methyl derivatives
exhibited marked pigment response. 8-methoxy-
psoralen was less active than psoralen or its
methyl derivatives. Where as 5ig or lOjig of
psoralen or its methyl derivatives produced + to
+ + grade erythema and pigmentation, it re-
quired 25 jig of 8-methoxypsoralen to produce +
grade erythema and pigmentation response.
5-Methoxypsoralen exhibited a lesser response
than 8-methoxypsoralen topically as well as
orally. It is interesting to see that all these com-
pounds exhibited comparatively a similar re-
sponse on guinea pig and human skin.
This bioassay procedure affords a convenient
method of screening photodynamically active
and inactive compounds. The relationship
between the relative activity of various com-
pounds in terms of molecular configuration can
thus be studied.
In the oral studies with guinea pigs, the mini-
mum effective concentration for most of the
active compounds was 0.02 millimols. Below this
concentration range no response was observed.
Coumarin compounds totalling twenty-eight were
tested. Except limetin and 2-thiocoumarin, all
the rest were inactive. Limetin and thiocoumarin
were active topically in the higher concentration
range only and when given orally even in high
doses they showed no photodynarnic response.
It is evident from Table II that coumarin and its
other derivatives do not possess the active ring
configuration for photodynamic response on the
mammalian skin.
Furochromone compounds represented by
kheffin, chellol glucoside and visnagin (Table
III) do not exhibit any photodynamie response.
Compounds like furan and benzofuran have been
already reported to be inactive molecules (11).
Furacin and an open chain compound cinnamic
acid, related structurally to coumarin, were also
found to be inactive. It is apparent that furan
ring alone does not possess photodynamic activ-
ity. Only when it is fused with coumarin ring,
as shown by psoralen action, the molecule ex-
hibits photodynamic action.
DISCUSSION
The furocoumarin ring configuration represents
a fused structure of furan and coumarin rings.
The unsubstituted psoralen molecule has been
shown to exhibit an optimum photodynamic
action in presence of long wave ultraviolet light
(13, 14). Photodynamie action in mammalian
skin in presence of these compounds and ultra-
violet light above 3200 A would be reflected by
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biological changes of increased erythema and
pigmentation. Topical application and oral ad-
ministration of different furocoumarins, eou-
marina, furoehromones, and other compounds to
albino guinea pig and human skin has revealed
the relationship of molecular configuration to the
activity of various compounds.
The furan ring structure does not possess any
erythema inducing action. Topical application
of twenty-eight compounds containing the cou-
mann ring configuration did not show any
photoactivation with the exception of thiocou-
mann and limetin which showed weak positive
response. The erythema response with thiocou-
marin and limetin may be due to slight traces of
impurity of active psoralens. Orally these differ-
ent derivatives of coumanin did not show any
erythemal response. Even the monomethyl,
dimethyl and trimethylcoumanin derivatives
which presumably have increased the electron
density of carbon atoms, did not exhibit photo-
dynamic effect. The psoralen molecule which has
a fused ring structure of furan and coumarin
shows highest activity. The absorption spectra
of this molecule reveals four peaks at 212 mji, 245
mgi, 294 m and 320 mz. Other compounds such
as different methyl derivatives of psoralen,
8-methoxypsoralen, 5-methoxypsoralen also re-
veal some characteristic absorption in long wave
ultraviolet region. Although the action spectra
and absorption spectra of the active compounds
have not been completely determined, character-
istic absorption of these molecules in long wave
ultraviolet region can be said to be one of the
factors which make these molecules photody-
namically active. Long wave ultraviolet light
alone does not induce increased erythema and
pigmentation, but in presence of these molecules,
these biological changes are observed.
There are active sites in the parent furocou-
mann molecule which are favorable for photon
induced activation. The active centers in psoralen
molecule are: (a) valence bonds between carbon
3 and 4, (b) carbon atoms 5 and 8, (c) and intact
lactone ring, (d) a furan and coumarin ring
fusion at carbon 6 and 7 to give a linearly annu-
lated structure of furocoumarin molecule, (e) an
unsaturated linkage between carbon atoms 4'
and 5'.
Furochromone molecule as studied in three of
its derivatives, has an altered 3—4 valence bond.
These compounds are inactive. Fowlks (15) has
shown that open lactone ring compound furo-
coumaric acid without any substitution at other
carbon atoms, is an inactive molecule.
Methyl radicals which are known to increase
the electron density and carcinogenic activity
in carcinogenic compounds, however, do not
increase the erythema inducing property of
psoralen on human skin. But tnimethyipsoralen
exhibits the greatest response in guinea pig skin
as compared to other active compounds. Methyl
substitution does not affect the active centers in
psoralen molecule as all the three methyl deriva-
tives were found to be active. Comparatively, tn-
methyipsoralen was more active than dimethyl
or monomethylpsoralen, both on human skin
and guinea pig skin. It can be said that methyl
derivatives exhibit equally high activity and that
methyl substitution does not alter the activity
of psoralen molecule.
8-methoxypsoralen, 5-methoxypsoralen are
less active compounds. Substitution with meth-
oxy group at carbon 5 or 8 results in decreased
activity. 5, 8-dimethoxypsoralen is completely
inactive. The electron density of carbon atoms S
and 8 is altered by methoxy substitution, these
reactive carbon centers therefore exhibit less
activity. Substitution with amino or nitro group
at carbon 5 or hydroxyl group at carbon 8 reveals
the same effect of inactivation. It appears that
the electronic character of the substituent and the
resonance stabilization of the compound may
well be of importance. The increase or decrease in
electron density at various positions in this ring
system may influence the relative activity of
these compounds. Substitution with nitro, amino,
hydroxy, methoxy groups probably results in the
decreased electronic charge in the ring system
which therefore render the compound inactive or
less active. Methyl substituents probably donate
more electronic charge to the parent compound
and therefore reveal significant photodynamic
action.
4' ,5'-dihydro-8-methoxypsoralen possesses
very low activity when applied topically and
when given orally does not show any photoacti-
vation. 4', 5'-dihydro-4-methylpsoralen is com-
pletely inactive molecule topically as well as
orally. Methyl substitution at carbon 5',(5'-
niethylpsoralen) does not reveal any loss of
activity since the valence bonds between carbon
4'-5' is still unsaturated. It appears that un-
saturated linkage is needed at these carbon
atoms for the molecule to be photodynamically
active.
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The linkage of furan ring with coumarin ring
at carbon 6 and 7 is essential. Furan ring attached
to carbon 7 and 8 as shown in 5-methoxyiso-
psoralen (isobergapten) and dimethylisopsoralen
structure inactivates these compounds. It is thus
evident that linearly annulated unsubstituted
structure of furocoumarin psoralen possesses the
maximum activity. Non-linear structure like
isopsoralen molecule loses its activity. Pigmenta-
tion response also reveals the same relationship
between structural configuration and activity of
the compound.
SIThIMARY
Compounds of the furocoumarin group which
induce erythema and pigmentation of skin fol-
lowing exposure to long wave ultraviolet radiant
energy were tested on albino guinea pig and
human skin for their relative activity along with
other structurally related coumarin, furochro-
mone and furan ring configuration compounds.
A bioassay method for screening active and
inactive compounds has been developed.
Out of 18 furocoumarin compounds which were
tested, psoralen followed by three methyl deriv-
atives of psoralen were found to be most active.
Compounds possessing a furan ring configura-
tion, coumarin ring configuration and furo-
chromone structures do not possess photodynamic
action. A fused structure of furan and coumarin
as present in psoralen molecule is essential for
photodynamic response. A linearly annulated
ring structure of psoralen shows optimum cry-
thema and pigment inducing action. The non-
linear angular structure of isopsoralen molecule
loses its photodynamic action. The relationship
of molecular configuration to the photodynamic
activity of various compounds is discussed.
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DISCUSSION
DR. STEPHEN ROTHMAN (Chicago, Ill.): This
is a beautiful analysis of the relationship of struc-
ture and biological effect. I would like to ask why
some carbon atoms are given two numbers in
the formulas shown. This is somewhat confusing
to me.
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Dn. EARL G. MCNALL (Los Angeles, Calif.):
These fascinating experiments point up dramat-
ically the general requirements of compounds
which are capable of photosensitization. Com-
pounds which cause photosensitivity must be
capable of trapping radiant energy and fluorescing
energy at longer wave-lengths. There are several
well-known biological materials which have the
properties of photosensitization. Many of the
tetrapyrolls such as hematin, protohematin,
chlorophyll, and similar compounds are resonance
stabilized and floresce radiant energy. The
photosensitivity of the psoralen series is greatest
in those compounds with free radical intermedi-
ates which have the highest resonance stabiliza-
tion and significantly lower with those com-
pounds in which resonance stabilization is
interferred with at appropriately substituted
sites.
DR. EDMUND KLEIN (Boston, Mass.): I
wonder if you have any data with regard to
combining the inactive with the active mole-
cules—any competitive inhibition or other inter-
ference?
M. A. PATHAK (in closing): Dr. Rothman,
I agree that in the psoralen molecule carbon
atoms number 6 and 7 of the coumarin ring have
been numbered as 3' and 2' in the furan ring.
The numbering of these carbon atoms of the
coumarin and furan rings in the furocoumarin
ring structure has always presented a problem to
the organic chemists. Varying numbering systems
are being practised in different laboratories. The
numbering system which has been adopted in
our laboratory had been originally proposed by
Dr. SpMh, one of the leading German organic
chemists, who has done considerable work in the
synthesis of different furocoumarins. Labelling
the hetero oxygen atom as 1, the numbering of
other carbon atoms in the coumarin ring starts
in a clockwise direction. Similarly, the prime
numbering system in the furan ring starts from
the hetero atom, and goes in clockwise direction.
This is just for simplification, so that the fusion
of furan and coumarin ring at particular carbon
atoms is understood by the reader without con-
fusion. Otherwise, I must say that there are only
2 carbon atoms in that position and not four. In
the isopsoralen structure, carbon atoms 2' and 3'
of the furan ring have retained their identity, and
thus simplified the identification of the site of
fusion with carbon atoms 7 and 8 of the cou-
mann ring.
With regard to Dr. McNall's question relative
to the stabilization with free radicals in chloro-
phyll and other hematoporphorins, I can say that
the formation of activated molecules in photo-
chemical reactions of chlorophyll and other
photodynamic processes have been postulated. A
photosensitized, long-lived excitation state of
chlorophyll has been believed to exist in the
process of oxidation reduction. Energy transfer
from molecule to molecule can occur by photo-
sensitized fluorescence and induced resonance. I
thank him for the other thoughtful comments.
I would like to state further that if one studies the
chemical structures of photodynamically active
compounds such as methylene blue, furocou-
marins and compounds with porphyrin rings, etc.,
one will observe that they all have a tnicyclic
condensed aromatic ring structure resembling
anthracene. Dr. Fowlks from our laboratory be-
lieves that those compounds possessing such
linear annulations, with or without hetero atoms,
will show some photodynamic action.
In answer to question three with regard to the
active and inactive combination of the com-
pounds and their effect on photodynamic action,
I cannot say precisely what will happen since we
have not yet carried out that study. We thank
you for the suggestions and we will try to do
them.
